Ernexa Therapeutics Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KErnexa Therapeutics Inc.ERNAW3d

   Ernexa Therapeutics releases investor presentation

   • Filed Form 8-K on 2026-10-15
   • Presentation attached as Exhibit 99.1
   • Website used for distributing company info
2. ROUTINE3Ernexa Therapeutics Inc.ERNAWSep 22

   Robert J. Spiegel, new insider at ERNAW

   Robert J. Spiegel, reporting

3. ROUTINE8-KErnexa Therapeutics Inc.ERNAWSep 16

   Current report

4. ROUTINE8-KErnexa Therapeutics Inc.ERNAWSep 16

   Current report

5. ROUTINE4Ernexa Therapeutics Inc.ERNAWSep 1

   6 insider filings

   James Arthur Bristol, insider filing for ERNAW

   Show all 6

   • 4Insider filing for ERNAWSep 1
   • 4Insider filing for ERNAWSep 1
   • 4Insider filing for ERNAWSep 1
   • 4Insider filing for ERNAWSep 1
   • 4Insider filing for ERNAWSep 1
   • 4Insider filing for ERNAWSep 1

   James Arthur Bristol, reporting

6. ROUTINE3Ernexa Therapeutics Inc.ERNAWAug 27

   David Polinsky, new insider at ERNAW

   David Polinsky, reporting

7. NOTABLE10-QErnexa Therapeutics Inc.ERNAWAug 6

   Quarterly report

8. ROUTINE8-KErnexa Therapeutics Inc.ERNAWJul 2

   Current report

9. ROUTINE8-KErnexa Therapeutics Inc.ERNAWJul 2

   Current report

10. ROUTINE8-KErnexa Therapeutics Inc.ERNAWJun 26

    Current report

11. ROUTINESCHEDULE 13G/AErnexa Therapeutics Inc.ERNAWMay 20

    Ownership stake disclosure by CLEAR STREET LLC (amended)

    CLEAR STREET LLC, filed by

12. ROUTINESCHEDULE 13G/AErnexa Therapeutics Inc.ERNAWMay 15

    2 13G filings

    Ownership stake disclosure by Freebird Partners LP (amended)

    Show all 2

    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15
    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15

    Freebird Partners LP, filed by

13. ROUTINESCHEDULE 13GErnexa Therapeutics Inc.ERNAWMay 14

    Ownership stake disclosure by Bleichroeder LP

    Bleichroeder LP, filed by

14. ROUTINESCHEDULE 13GErnexa Therapeutics Inc.ERNAWMay 14

    Ownership stake disclosure by CLEAR STREET LLC

    CLEAR STREET LLC, filed by

15. ROUTINESCHEDULE 13G/AErnexa Therapeutics Inc.ERNAWMay 13

    Ownership stake disclosure by Shameek Konar (amended)

    Shameek Konar, filed by

16. ROUTINEARSErnexa Therapeutics Inc.ERNAWMay 11

    Annual report to shareholders

17. ROUTINEDEFA14AErnexa Therapeutics Inc.ERNAWMay 11

    Additional proxy materials

18. ROUTINEDEF 14AErnexa Therapeutics Inc.ERNAWMay 11

    Proxy statement

19. NOTABLE10-QErnexa Therapeutics Inc.ERNAWMay 11

    Quarterly report

20. ROUTINE8-KErnexa Therapeutics Inc.ERNAWMay 4

    Current report

21. ROUTINEDEF 14CErnexa Therapeutics Inc.ERNAWApr 13

    DEF 14C filing

22. ROUTINEPRE 14CErnexa Therapeutics Inc.ERNAWApr 1

    PRE 14C filing

23. ROUTINEEFFECTErnexa Therapeutics Inc.ERNAWMar 31

    Registration declared effective

24. ROUTINES-3/AErnexa Therapeutics Inc.ERNAWMar 24

    Securities offering (amended)

25. ROUTINE8-KErnexa Therapeutics Inc.ERNAWMar 20

    Current report

26. NOTABLE10-KErnexa Therapeutics Inc.ERNAWMar 13

    Annual report

27. ROUTINE8-KErnexa Therapeutics Inc.ERNAWFeb 26

    Current report

28. NOTABLESCHEDULE 13D/AErnexa Therapeutics Inc.ERNAWFeb 17

    Ownership stake disclosure by Charles Cherington (amended)

    Charles Cherington, filed by

29. ROUTINE4Ernexa Therapeutics Inc.ERNAWFeb 17

    Charles Cherington, insider filing for ERNAW

    Charles Cherington, reporting

30. ROUTINE8-KErnexa Therapeutics Inc.ERNAFeb 11

    Current report

31. ROUTINE424B5Ernexa Therapeutics Inc.ERNAFeb 10

    Securities offering

32. ROUTINEEFFECTErnexa Therapeutics Inc.ERNAFeb 6

    Registration declared effective

33. ROUTINECERTErnexa Therapeutics Inc.ERNAFeb 5

    CERT filing

34. ROUTINE8-A12BErnexa Therapeutics Inc.ERNAFeb 5

    8-A12B filing

35. ROUTINES-1/AErnexa Therapeutics Inc.ERNAFeb 5

    Securities offering (amended)

36. ROUTINES-1/AErnexa Therapeutics Inc.ERNAFeb 4

    Securities offering (amended)

37. ROUTINESCHEDULE 13G/AErnexa Therapeutics Inc.ERNADec 19, 2025

    Ownership stake disclosure by Freebird Partners LP (amended)

    Freebird Partners LP, filed by

38. ROUTINESCHEDULE 13G/AErnexa Therapeutics Inc.ERNADec 16, 2025

    Ownership stake disclosure by Shameek Konar (amended)

    Shameek Konar, filed by

39. ROUTINE8-KErnexa Therapeutics Inc.ERNADec 11, 2025

    Current report

40. NOTABLE10-QErnexa Therapeutics Inc.ERNANov 7, 2025

    Quarterly report

Older filings on EDGAR